Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0341503 (
bacterial peritonitis
)
1,303
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Protease activation and protease-antiprotease interactions were sequentially studied in two different groups of patients with peritonitis. The biochemical changes were related to the cause of the disease and to the clinical course. Protease activation and
protease inhibitor
consumption were most pronounced in the peritoneal fluid, especially in
bacterial peritonitis
. Plasma changes also indicated activation of the complement, kinin, and fibrinolytic systems and
protease inhibitor
consumption, especially of alpha 2-macroglobulin and antithrombin III. There was no significant difference between chemical and
bacterial peritonitis
regarding these plasma changes. Immunohistologic studies showed evidence of active uptake of protease-antiprotease complexes in macrophage-like cells in the peritoneum in both groups. It is concluded that peritonitis results in protease activation and
protease inhibitor
consumption, especially in the peritoneal fluid. The peritoneum has an active role in the clearance of protease-antiprotease complexes. The intensity, not the type, of the intra-abdominal challenge determines the biochemical changes in peritonitis.
...
PMID:Proteases and protease inhibitor balance in peritonitis with different causes. 247 16